<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M890</article-id>
      <article-id pub-id-type="publisher-id">molbank-2016-M890</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>(<italic>S</italic>)-4-[(3a<italic>R</italic>,4<italic>S</italic>,7a<italic>R</italic>)-4-Methoxy-6-methyl-3-methylene-2-oxo-2,3,3a,4,7,7a-hexahydrobenzofuran-5-yl]pentyl Acetate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Xin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Jin-Ming</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Jiang-Jiang</given-names>
          </name>
          <xref rid="c1-molbank-2016-M890" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2016-M890">College of Science, Northwest A&amp;F University, Yangling 712100, China; <email>nxlxguoxin@163.com</email> (X.G.); <email>jinminggao@nwsuaf.edu.cn</email> (J.-M.G.)</aff>
      <author-notes>
        <corresp id="c1-molbank-2016-M890"><label>*</label>Correspondence: <email>tangjiang11@nwsuaf.edu.cn</email>; Tel.: +86-298-709-2235</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>03</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2016</year>
      </pub-date>
      <volume>2016</volume>
      <issue>1</issue>
      <elocation-id>M890</elocation-id>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>01</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>03</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A new etherified 1-<italic>O</italic>-acetylbritannilactone (ABL) analogue <bold>2</bold> was semi-synthesized by a mild etherification reaction. The structure of the newly synthesized analogue was identified by <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and HR-ESI-MS analysis. <bold>2</bold> exhibited similar cytotoxicity against HCT116, SGC-7901 and HeLa human cancer cell lines with ABL.</p>
      </abstract>
      <kwd-group>
        <kwd>1-<italic>O</italic>-acetylbritannilactone</kwd>
        <kwd>etherification</kwd>
        <kwd>cytotoxicity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2016-M890" sec-type="intro">
      <title>1. Introduction</title>
      <p>1-<italic>O</italic>-acetylbritannilactone (ABL, <bold>1</bold>, <xref ref-type="scheme" rid="molbank-2016-M890-f001">Scheme 1</xref>), a 1,10-<italic>seco</italic>-eudesmanolide sesquiterpene extracted from <italic>Inula britannica</italic> L. (Xuanfuhua in Chinese), has been reported to have a large number of biological effects including anti-inflammatory, antibacterial, antihepatitic, antidiabetes, and antitumor activities [<xref ref-type="bibr" rid="B1-molbank-2016-M890">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2016-M890">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2016-M890">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2016-M890">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2016-M890">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2016-M890">6</xref>]. It has been shown to possess anticancer effects in various cancer cells [<xref ref-type="bibr" rid="B2-molbank-2016-M890">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2016-M890">3</xref>,<xref ref-type="bibr" rid="B7-molbank-2016-M890">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2016-M890">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2016-M890">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2016-M890">10</xref>], including anti-proliferation, cell cycle arrest, induction of apoptosis and increased sensitivity to apoptosis. The relative configuration of ABL at the C4-methyl and C6-hydroxyl group have been revised as 4<italic>S</italic> *, 6<italic>S</italic> * using X-ray diffraction analysis by us [<xref ref-type="bibr" rid="B11-molbank-2016-M890">11</xref>].</p>
      <p>It has been reported that 6-hydroxy (6-OH) and &#x3B1;-methylene-&#x3B3;-lactone of ABL act as important bioactive motifs [<xref ref-type="bibr" rid="B12-molbank-2016-M890">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2016-M890">13</xref>]. Therefore, structure modifications for improving ABL bioactivity at both positions of ABL have been conducted by many medicinal chemists. Structural modifications of ABL have focused mainly on alterations at 6-OH moiety such as oxidation and acylation by Liu [<xref ref-type="bibr" rid="B12-molbank-2016-M890">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2016-M890">13</xref>,<xref ref-type="bibr" rid="B14-molbank-2016-M890">14</xref>] and us [<xref ref-type="bibr" rid="B11-molbank-2016-M890">11</xref>,<xref ref-type="bibr" rid="B15-molbank-2016-M890">15</xref>]. However, etherified ABL analogues have not been synthesized so far, perhaps due to the complexity of its structure (sensitive to strong acid or base) and larger steric hindrance. Because of this, using ABL as the starting material, we semi-synthesized a new etherified analogue 1-<italic>O</italic>-acetyl-6-methoxybritannilactone (<bold>2</bold>) (aslo named (<italic>S</italic>)-4-[(3a<italic>R</italic>,4<italic>S</italic>,7a<italic>R</italic>)-4-methoxy-6-methyl-3-methylene-2-oxo-2,3,3a,4,7,7a-hexahydrobenzofuran-5-yl]pentyl acetate) by a mild etherification reaction with Ag<sub>2</sub>O and dimethyl sulfide as 6-OH activation agents.</p>
    </sec>
    <sec id="sec2-molbank-2016-M890" sec-type="results">
      <title>2. Results and Discussion</title>
      <p>Ethers are usually prepared from alcohols or their conjugate bases. One important procedure, known as the Williamson Ether Synthesis, is proceeded by an SN<sub>2</sub> reaction of an alkoxide nucleophile with an alkyl halide. To synthesize etherified ABL analogues, a classic Williamson ether synthesis method was firstly carried out with ABL and CH<sub>3</sub>I using NaH or NaOMe as organic base at room temperature. However, the reaction was not observed under aprotic solvent conditions including acetone, THF and DMSO but in the presence of phase transfer catalysis triethylbenzylaminium chloride (TEBA). Finally, we used mild etherification reaction with Ag<sub>2</sub>O and dimethyl sulfide as 6-OH activation agents to obtain the methyl etherified analogue <bold>2</bold> in 85% yield (<xref ref-type="scheme" rid="molbank-2016-M890-f001">Scheme 1</xref>). Full characterization spectra of <bold>2</bold> refers to the <xref ref-type="app" rid="app1-molbank-2016-M890">supplement material</xref>.</p>
      <p>ABL and <bold>2</bold> were assayed for cytotoxicity against three human solid tumor cell lines, HCT116, SGC-7901 and HeLa by using a reported method [<xref ref-type="bibr" rid="B11-molbank-2016-M890">11</xref>], and the results (IC<sub>50</sub>) are shown in <xref ref-type="table" rid="molbank-2016-M890-t001">Table 1</xref>. <bold>2</bold> showed similar cytotoxicity with ABL against HCT116, SGC-7901 and HeLa, revealing the etherification reaction may not be an effective strategy to improve cytotoxic activity for ABL.</p>
    </sec>
    <sec id="sec3-molbank-2016-M890">
      <title>3. Materials and Methods</title>
      <sec id="sec3dot1-molbank-2016-M890">
        <title>3.1. General</title>
        <p>ABL was isolated from the EtOAc-soluble fraction of the ethanolic extract of the dried flowers of <italic>I. britannica</italic>, followed by repeated silica gel column chromatography purification [<xref ref-type="bibr" rid="B11-molbank-2016-M890">11</xref>]. Column chromatography (CC) was performed over silica gel (200&#x2013;300 mesh, Qingdao Marine Chemical Ltd., Qingdao, China). Compounds were visualized either in UV light (254 nm) and/or by staining with 5% phosphomolybdic acid followed by heating. All NMR spectra were recorded on a 500 MHz Bruker NMR spectrometer. HR-MS spectra were recorded on an Thermo Scientific LTQ Orbitrap XL spectrometer. Other chemicals used in this study were commercial analytical-grade reagents.</p>
      </sec>
      <sec id="sec3dot2-molbank-2016-M890">
        <title>3.2. Synthesis of (S)-4-[(3aR,4S,7aR)-4-Methoxy-6-methyl-3-methylene-2-oxo-2,3,3a,4,7,7a-hexahydrobenzofuran-5-yl]pentyl Acetate (or Named: 1-O-Acetyl-6-methoxybritannilactone)</title>
        <p>To a 5 mL round-bottomed flask containing ABL (0.1 mmol) in dry THF (3 mL) was added CH<sub>3</sub>I (2.0 mmol), Ag<sub>2</sub>O (0.5 mmol), Me<sub>2</sub>S (0.5 mmol), molecular sieve 4 &#xC5; (1.5 weight % of THF). The resulting solution was stirred at room temperature for 24 h. After completely by TLC test, the solution was washed with water, extracted with EtOAC, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, and further purified by the column chromatography to get the analogue <bold>2</bold> in the yield of 85%.</p>
        <p><italic>1-O-Acetyl-6-methoxybritannilactone (<bold>2</bold>)</italic>: yellow oil. <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) &#x3B4; 6.31 (d, <italic>J</italic> = 2.7 Hz, 1H, H-13a), 5.63 (d, <italic>J</italic> = 2.2 Hz, 1H, H-13b), 4.98&#x2013;4.92 (m, 1H, H-8), 3.99&#x2013;3.86 (m, 2H, H-1), 3.63&#x2013;3.54 (m, 1H, H-6), 3.38 (s, 3H, C<italic><underline>H</underline><sub>3</sub></italic>O-6), 2.75 (dd, <italic>J</italic> = 16.0, 2.6 Hz, 1H, H-9a), 2.67 (dd, <italic>J</italic> = 12.8, 7.8 Hz, 1H, H-4), 2.38 (dd, <italic>J</italic> = 16.0, 1.8 Hz, 1H, H-9b), 2.04 (s, 3H, C<italic><underline>H</underline><sub>3</sub></italic>CO-1), 1.74 (s, 3H, H-14), 1.46&#x2013;1.33 (m, 1H, H-2a), 1.29&#x2013;1.17 (m, 2H, H-2b and H-3a), 1.06&#x2013;0.92 (m, 4H, H-3b and H-15); <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) &#x3B4; 171.37 (CH<sub>3</sub><italic><underline>C</underline></italic>OO-1), 170.00 (C-12), 137.53 (C-11), 134.92 (C-10), 131.08 (C-5), 123.39 (C-13), 78.17 (C-8), 76.25 (C-6), 64.48 (C-1), 56.40 (<italic><underline>C</underline></italic>H<sub>3</sub>O-6), 39.97 (C-7), 34.54 (C-9), 33.02 (C-4), 31.64 (C-3), 26.73 (C-2), 21.12 (<italic>C</italic>H<sub>3</sub>COO-1), 20.44 (C-14), 18.83 (C-15). HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>18</sub>H<sub>27</sub>O<sub>5</sub> [M + H]<sup>+</sup> 323.18530, found 323.18524.</p>
      </sec>
    </sec>
   </body>
  <back> 
  <app-group>
  <app id="app1-molbank-2016-M890">
      <title>Supplementary Materials</title>
      <p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR and HR-ESI-MS spectra are reported in the supplementary materials as Figures S1&#x2013;S3. They and the molfiles are available online at <uri>http://www.mdpi.com/1422-8599/2016/1/M890</uri>.</p>
    </app>
  </app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>This project was supported by the National Natural Science Foundation of China (31200254), as well as Chinese Universities Scientific Fund (QN2012047).</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>J.-J.T. and J.-M.G. conceived and designed the experiments; X.G. performed the experiments; J.-J.T. analyzed the data; J.-M.G. contributed reagents/materials/analysis tools; J.-J.T. wrote the paper.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2016-M890">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>B.-N.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.-S.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>L.-Z.</given-names>
            </name>
            <name>
              <surname>Cordell</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Sesquiterpene lactones from <italic>Inula britannica</italic></article-title>
          <source>Phytochemistry</source>
          <year>1993</year>
          <volume>34</volume>
          <fpage>249</fpage>
          <lpage>252</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2016-M890">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Acetylbritannilactone suppresses growth via upregulation of kruppel-like transcription factor 4 expression in HT-29 colorectal cancer cells</article-title>
          <source>Oncol. Rep.</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>1181</fpage>
          <lpage>1187</lpage>
          <pub-id pub-id-type="pmid">21811764</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2016-M890">
        <label>3.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>C.-T.</given-names>
            </name>
            <name>
              <surname>Rafi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dipaola</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Ghai</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Inducing Cell Apoptosis and Treating Cancer Using 1-<italic>O</italic>-Acetylbritannilactone or 1,6-<italic>O</italic>,<italic>O</italic>-Diacetylbritannilactone</article-title>
          <source>U.S. Patent</source>
          <patent>6627623</patent>
          <day>30</day>
          <month>September</month>
          <year>2003</year>
        </citation>
      </ref>
      <ref id="B4-molbank-2016-M890">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>J.-L.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>X.-W.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.-B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.-Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D.-Q.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Q.-W.</given-names>
            </name>
          </person-group>
          <article-title>Sesquiterpene lactones and their anti-tumor activity from the flowers of <italic>Inula britannica</italic></article-title>
          <source>Lett. Drug Des. Discov.</source>
          <year>2008</year>
          <volume>5</volume>
          <fpage>433</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="doi">10.2174/157018008785909813</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2016-M890">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Je</surname>
              <given-names>K.-H.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>A.-R.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.-T.</given-names>
            </name>
            <name>
              <surname>Mar</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>E.-K.</given-names>
            </name>
          </person-group>
          <article-title>The inhibitory principle of lipopolysaccharide-induced nitric oxide production from <italic>Inula britannica</italic> var. <italic>Chinensis</italic></article-title>
          <source>Arch. Pharm. Res.</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>83</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02980051</pub-id>
          <pub-id pub-id-type="pmid">14969344</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2016-M890">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-kappa B activation</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <year>2008</year>
          <volume>324</volume>
          <fpage>292</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.107.127407</pub-id>
          <pub-id pub-id-type="pmid">17911374</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2016-M890">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rafi</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.-S.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>C.-T.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>DiPaola</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>A sesquiterpenelactone from <italic>Inula britannica</italic> induces anti-tumor effects dependent on Bcl-2 phosphorylation</article-title>
          <source>Anticancer Res.</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>313</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">15816553</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2016-M890">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D.Q.</given-names>
            </name>
          </person-group>
          <article-title>Acetylbritannilatone suppresses NO and PGE2 synthesis in Raw 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression</article-title>
          <source>Life Sci.</source>
          <year>2004</year>
          <volume>75</volume>
          <fpage>675</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lfs.2003.12.022</pub-id>
          <pub-id pub-id-type="pmid">15172177</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2016-M890">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>C.T.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of mapk, Bcl-2 family, cytochrome c, and caspases in induction of apoptosis by 1,6-<italic>O</italic>,<italic>O</italic>-diacetylbritannilactone in human leukemia cells</article-title>
          <source>Mol. Nutr. Food Res.</source>
          <year>2007</year>
          <volume>51</volume>
          <fpage>229</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1002/mnfr.200600148</pub-id>
          <pub-id pub-id-type="pmid">17262884</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2016-M890">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y.P.</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D.Q.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>1,6-<italic>O</italic>,<italic>O</italic>-diacetylbritannilactones inhibits IkappaB kinase beta-dependent NF-kappaB activation</article-title>
          <source>Phytomedicine</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="doi">10.1016/j.phymed.2008.08.003</pub-id>
          <pub-id pub-id-type="pmid">18926678</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2016-M890">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J.-J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.-C.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>J.-M.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J.-T.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>J.-M.</given-names>
            </name>
          </person-group>
          <article-title>Semisynthesis and <italic>in vitro</italic> cytotoxic evaluation of new analogues of 1-<italic>O</italic>-acetylbritannilactone, a sesquiterpene from <italic>Inula britannica</italic></article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2014</year>
          <volume>80</volume>
          <fpage>71</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.04.028</pub-id>
          <pub-id pub-id-type="pmid">24763364</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2016-M890">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>C.T.</given-names>
            </name>
          </person-group>
          <article-title>Studies on 1-<italic>O</italic>-acetylbritannilactone and its derivative, (2-<italic>O</italic>-butyloxime-3-phenyl)-propionyl-1-<italic>O</italic>-acetylbritannilactone ester</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>1101</fpage>
          <lpage>1104</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2003.12.078</pub-id>
          <pub-id pub-id-type="pmid">14980644</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2016-M890">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>C.T.</given-names>
            </name>
          </person-group>
          <article-title>Design, synthesis, and anti-tumor activity of (2-<italic>O</italic>-alkyloxime-3-phenyl)-propionyl-1-<italic>O</italic>-acetylbritannilactone esters</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>2783</fpage>
          <lpage>2789</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2005.02.024</pub-id>
          <pub-id pub-id-type="pmid">15781389</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2016-M890">
        <label>14.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Pharmaceutical Application of Derivant of Benzofuran-Ketone</article-title>
          <patent>CN1445221A</patent>
          <day>1</day>
          <month>October</month>
          <year>2003</year>
        </citation>
      </ref>
      <ref id="B15-molbank-2016-M890">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 1-<italic>O</italic>-acetylbritannilactone analogues from <italic>Inula britannica</italic> and <italic>in vitro</italic> evaluation of their anticancer potential</article-title>
          <source>Med. Chem. Comm.</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>1584</fpage>
          <lpage>1589</lpage>
          <pub-id pub-id-type="doi">10.1039/C4MD00209A</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme and Table</title>
      <fig id="molbank-2016-M890-f001" position="float">
        <object-id pub-id-type="pii">molbank-2016-M890-f001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 1-<italic>O</italic>-acetyl-6-methoxybritannilactone (<bold>2</bold>). <italic>Reagents and conditions</italic>: CH<sub>3</sub>I (20 eq.), Ag<sub>2</sub>O (5 eq.), molecular sieve 4 &#xC5; (1.5 w%), CH<sub>3</sub>SCH<sub>3</sub> (5 eq.), THF, rt, 24 h.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2016-M890-g001.tif"/>
      </fig>
      <table-wrap id="molbank-2016-M890-t001" position="float">
        <object-id pub-id-type="pii">molbank-2016-M890-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Cytotoxic activities (IC<sub>50</sub>) of 1-<italic>O</italic>-acetylbritannilactone (ABL) and etherified analogue <bold>2</bold>.</p>
        </caption>
         <table>
          <thead>
            <tr>
              <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">No.</th>
              <th colspan="3" align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin">IC<sub>50</sub> <sup>1</sup> (&#x3BC;M)</th>
            </tr>
            <tr>
              <th align="center" valign="top" style="border-bottom:solid thin">HCT116</th>
              <th align="center" valign="top" style="border-bottom:solid thin">SGC-7901</th>
              <th align="center" valign="top" style="border-bottom:solid thin">HeLa</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle">ABL (<bold>1</bold>)</td>
              <td align="center" valign="top">36.1 &#xB1; 3.1</td>
              <td align="center" valign="top">42.5 &#xB1; 6.1</td>
              <td align="center" valign="top">32.6 &#xB1; 2.5</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>2</bold></td>
              <td align="center" valign="top">35.7 &#xB1; 5.2</td>
              <td align="center" valign="top">37.5 &#xB1; 3.8</td>
              <td align="center" valign="top">38.6 &#xB1; 2.9</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin">VP-16</td>
              <td align="center" valign="top" style="border-bottom:solid thin">2.13 &#xB1; 0.23</td>
              <td align="center" valign="top" style="border-bottom:solid thin">6.56 &#xB1; 0.68</td>
              <td align="center" valign="top" style="border-bottom:solid thin">2.97 &#xB1; 0.25</td>
            </tr>
          </tbody>
        </table>
		<table-wrap-foot>
          <fn>
            <p><sup>1</sup> The IC<sub>50</sub> values represent the concentration that causes 50% inhibition of cell viability. Cells were treated with ABL and <bold>2</bold> for 72 h. All data (mean &#xB1; SD) are the average of three or four determinations. Cancer cell lines: HCT116 (human colorectal cancer), SGC-7901 (human gastric cancer), HeLa (human cervix cancer). VP-16 represents etoposide (a positive control).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
  </back>
</article>
